DIPRIVAN

This brand name is authorized in United States. It is also authorized in Brazil, Canada, Cyprus, Ecuador, France, Hong Kong SAR China, Ireland, Japan, Mexico, Netherlands, New Zealand, Nigeria, Poland, South Africa, Spain, UK.

Active ingredients

The drug DIPRIVAN contains one active pharmaceutical ingredient (API):

1	Propofol UNII YI7VU623SF - PROPOFOL
	Propofol (2, 6-diisopropylphenol) is a short-acting general anaesthetic agent with a rapid onset of action of approximately 30 seconds.
	Read more about Propofol

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DIPRIVAN Emulsion for injection or infusion	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N01AX10	Propofol	N Nervous system → N01 Anesthetics → N01A Anesthetics, general → N01AX Other general anesthetics
Discover more medicines within N01AX10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	505618040043417, 505618040043517, 505618040043617, 505618040043717, 505618040043817, 505618040043917
CA	Health Products and Food Branch	02018950
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	25.364-10-03, 28011-06-09
ES	Centro de información online de medicamentos de la AEMPS	58785, 60744
FR	Base de données publique des médicaments	60616445, 62010414
GB	Medicines & Healthcare Products Regulatory Agency	43550, 47639, 47817
HK	Department of Health Drug Office	27322
JP	医薬品医療機器総合機構	1119402A1022, 1119402A2029, 1119402A3033, 1119402G1025, 1119402G2021
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	311M87
NG	Registered Drug Product Database	A4-6962, A4-6963
Switch country to Nigeria in order to find specific presentations of DIPRIVAN
NL	Z-Index G-Standaard, PRK	44652, 44660
NZ	Medicines and Medical Devices Safety Authority	3438, 8798
PL	Rejestru Produktów Leczniczych	100019367
US	FDA, National Drug Code	63323-269, 65219-800
ZA	Health Products Regulatory Authority	31/2.1/0375, 31/2.1/0376, 36/2.1/0084, 36/2.1/0085, 36/2.1/0086, T/2.1/226, X/2.1/30, X/2.1/31